» Articles » PMID: 30806803

Diagnostic Performance of CT in Detection of Metastatic Cervical Lymph Nodes in Patients with Thyroid Cancer: a Systematic Review and Meta-analysis

Overview
Journal Eur Radiol
Specialty Radiology
Date 2019 Feb 27
PMID 30806803
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Although ultrasound (US) is a standard modality for the assessment of cervical lymph node metastasis in patients with thyroid cancer, there is an increasing trend in the number of articles describing the use of contrast-enhanced computed tomography (CT). The purpose of this systematic review and meta-analysis was to evaluate the diagnostic performance of CT in the diagnosis of metastatic cervical lymph nodes and to identify the parameters responsible for heterogeneity in diagnostic performance.

Methods: Ovid-MEDLINE and EMBASE databases were searched up to May 22, 2018, for studies on the diagnostic performance of CT. The pooled sensitivity and specificity of all studies were calculated. In addition, subgroup analysis and meta-regression analysis were performed to evaluate factors responsible for heterogeneity.

Results: Seventeen (6378 patients, 11,590 lymph nodes) studies were included. The pooled sensitivity was 55% (95% CI, 47-63%), and the pooled specificity was 87% (95% CI, 90-95%). Higgins I statistic demonstrated substantial heterogeneity in the sensitivity (I = 96.3%) and specificity (I = 93.8%). In a per-neck level subgroup analysis, the Higgins I statistic demonstrated reduced heterogeneity in both sensitivity and specificity. In the meta-regression analysis, variation in the CT protocols, such as contrast amount, scan phase, and reconstruction slice thickness, was a statistically significant factor causing heterogeneity.

Conclusions: CT demonstrated acceptable diagnostic performance in the pre- and postoperative diagnosis of metastatic cervical lymph nodes in patients with thyroid cancer. Variation in the CT protocols was a main factor causing heterogeneity among the included studies.

Key Points: • The role of contrast-enhanced computed tomography (CT) needs to be reassessed. • CT demonstrated acceptable diagnostic performance in the diagnosis of metastatic cervical lymph nodes in patients with thyroid cancer in the meta-analysis. • Variation in the CT protocols was a main factor causing heterogeneity in the meta-regression analysis.

Citing Articles

Plasma exchange as a rescue therapy for treatment-resistant thyroid storm with concurrent heart failure: a literature review based on a case report.

Ebrahimi P, Payab M, Taheri M, Sefidbakht S, Alipour N, Hasanpour T Int J Emerg Med. 2024; 17(1):195.

PMID: 39710667 PMC: 11664921. DOI: 10.1186/s12245-024-00783-2.


A nomogram for risk stratification of central cervical lymph node metastasis in patients with papillary thyroid carcinoma.

Zou Y, Shi Y, Bi H, Tan J, Guo Q, Qin Y Quant Imaging Med Surg. 2024; 14(7):5084-5098.

PMID: 39022275 PMC: 11250316. DOI: 10.21037/qims-24-284.


Enhancement on CT for preoperative diagnosis of metastatic lymph nodes in thyroid cancer: a comparison across experience levels.

Roh Y, Chung S, Yang S, Baek J, Choi Y, Sung T Eur Radiol. 2024; 35(1):20-28.

PMID: 38980412 DOI: 10.1007/s00330-024-10919-w.


The efficacy and assessment value of the level of thyroglobulin wash-out after fine-needle aspiration cytodiagnosis in the evaluation of lymph node metastasis in papillary thyroid carcinoma.

Chen J, Lin Z, Xu B, Lu T, Zhang X World J Surg Oncol. 2024; 22(1):149.

PMID: 38840197 PMC: 11151531. DOI: 10.1186/s12957-024-03430-5.


Role of computed tomography in the evaluation of regional metastasis in well-differentiated thyroid cancer.

Vaish R, Mahajan A, Sable N, Dusane R, Deshmukh A, Bal M Front Radiol. 2023; 3:1243000.

PMID: 38022790 PMC: 10643764. DOI: 10.3389/fradi.2023.1243000.


References
1.
Eisenkraft B, Som P . The spectrum of benign and malignant etiologies of cervical node calcification. AJR Am J Roentgenol. 1999; 172(5):1433-7. DOI: 10.2214/ajr.172.5.10227533. View

2.
Jadvar H, McDougall I, Segall G . Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 1999; 19(6):547-54. DOI: 10.1097/00006231-199806000-00006. View

3.
Rubello D, Mazzarotto R, Casara D . The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med. 2000; 27(4):431-40. DOI: 10.1007/s002590050527. View

4.
Deeks J . Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001; 323(7305):157-62. PMC: 1120791. DOI: 10.1136/bmj.323.7305.157. View

5.
Sivanandan R, Soo K . Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg. 2001; 88(9):1241-4. DOI: 10.1046/j.0007-1323.2001.01843.x. View